Libra Infusions Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Libra Infusions's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals Industry Growth | 11.0% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 30 Jun 2019 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Libra Infusions makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 19 | 197 | 2 | 56 | 0 |
30 Jun 18 | 191 | 6 | 61 | 0 |
31 Mar 18 | 191 | -16 | 60 | 0 |
31 Dec 17 | 241 | 5 | 62 | 0 |
30 Sep 17 | 245 | 5 | 62 | 0 |
30 Jun 17 | 244 | 6 | 63 | 0 |
31 Mar 17 | 290 | 5 | 67 | 0 |
31 Dec 16 | 259 | 3 | 63 | 0 |
30 Sep 16 | 231 | 8 | 60 | 0 |
30 Jun 16 | 238 | 6 | 57 | 0 |
31 Mar 16 | 232 | 9 | 62 | 0 |
31 Dec 15 | 247 | 6 | 61 | 0 |
30 Sep 15 | 272 | -4 | 59 | 0 |
30 Jun 15 | 287 | 4 | 59 | 0 |
30 Jun 14 | 282 | 7 | 55 | 0 |
30 Jun 13 | 227 | 5 | 45 | 0 |
Quality Earnings: Insufficient data to determine if LIBRAINFU has high quality earnings.
Growing Profit Margin: Insufficient data to determine if LIBRAINFU's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if LIBRAINFU's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare LIBRAINFU's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if LIBRAINFU's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: LIBRAINFU has a negative Return on Equity (0%), as it is currently unprofitable.